3D Cell Culture Market Information: By Technique (Scaffolds Based 3D Cell Culture, Scaffold-Free 3D Cell Culture), Product (Consumables), Application (Cancer Research) and End-User (Pharmaceutical & Biotechnology Companies) - Forecast till 2027
ID: MRFR/LS/4472-CR | May 2018 | Region: Global | 100 pages
Speak to Analyst
Request a Free Sample
3D Cell Culture Market Overview
Market Research Future (MRFR) studied the 3D Cell Culture Market 2020 across the analysis period till 2027. As per MRFR analysis, the cell culture market can rise at 16% CAGR during the forecast tenure to Reach USD 3,721 Million by 2027. By 2027, the 3D cell culture market size can rise considerably. The artificially created environment that supports biological cells to grow and interact with their surroundings in all three dimensions is called 3D cell culture. Unlike 2D environments, such as; Petri dish, a 3D cell culture aid cells to grow in all directions in in-vitro condition, similar to how they would respond in the in-vivo condition.
COVID-19 Analysis
The outbreak of the COVID-19 pandemic is observed to significantly impact the 3D cell culture market for the study period. Firms have had to pause their production processes due to inconvenience in supply chain solutions and decline in demand for products. The growth status of the 3d cell culture market competitors amidst COVID 19 is also studied by researchers to estimate the business earned by the end of the study period.
Market Dynamics
Drivers
Rise in Application of Biotech Applications to Support Market Rise
The expansion of the cancer population is creating the demand for effective biotech solutions to launch some effective cure. This is expected to contribute to the expansion of the 3D cell culture market by 2023. The increase in demand for organ transplantation and the need to mitigate risks associated with such surgeries can also contribute to the expansion of the 3D cell culture market.
Opportunities
Entrance of Companies Exploring Untapped Potential of Market
An increase in growth scope of the 3D cell culture market as companies are taking initiative to explore untapped potential of the market. Hike in investment in stem cell research and growing application of 3D cell culture in the treatment of cancer can add to the market surge through the review period.
Restraints
Stringent Regulatory Framework to Hinder Market
The growing expenses of modern equipment and stringent regulatory framework can restrain the market upsurge in the years to come.
Segment Overview
By Technique
The scaffold-based cell culture segment can rise at high pace through the analysis period. The increase in awareness about benefits of scaffold cell culture, such as facilitation of oxygen, waste transport, and nutriment, can add to the market upsurge in the analysis period.
By Product
The consumables segment can thrive at high pace due to rise in cognizance about major advantages offer by them. The easy accessibility of raw materials, such as hydrogel and others can add to the market upsurge. The consumables segment can thrive at a 25.88% CAGR by 2023.
By Application
The cancer research segment can gain momentum across the study tenure. The increase in number of cancer patients creating the urgency to design effective cure and treatment can cause the cancer research segment to thrive in the years to come. The drug discovery segment can expand at 25.75% CAGR through the analysis period.
By End-User
The pharmaceutical & biotechnology companies’ segment can expand at 26.13% CAGR by 2023. The pharmaceutical and biotechnology companies’ segment can earn considerable profit in the years to come. The increase in research and development undertakings by multiple contract research organizations can contribute to the market upsurge.
Regional Analysis
Americas 3D Cell Culture Market to Earn Considerable Profit
The Americas 3D cell culture market can surge at 27.79% CAGR across the review period till 2023. By 2023, the 3D cell culture market can value at USD 1318.73 Mn by 2023 from USD 279.77 Mn in 2016. North America can secure the largest market share of about 78.8% of the total regional market.
Europe 3D Cell Culture Market to Rise at High Pace
Europe is known to host reputed dealers in 3D cell culture. Companies with high-profit margin, such as Lonza, Thermo Fisher Scientific Inc, Kuraray Co Ltd, Corning Incorporated, Merck KGaA, and Becton & Dickinson and Company among others can earn huge revenue for the 3D cell culture market.
Asia Pacific 3D Cell Culture Market to Thrive in Coming Years
Increase in cases of drug discoveries and surge in need for organ transplantation are some prominent causes that can aid the Asia Pacific 3D market to rise at high pace through the analysis period. The need to curb risk factors in organ transplantation can contribute to the rise of the regional 3D cell culture market.
Competitive Landscape
Top-notch companies that are invested in the market are profiled in the report. MRFR analysts studied growth strategies, marketing policies, and other important expansion plans of these companies, and explained vividly in the report that can aid prominent investors make decent plans.
List of Key Companies Covered in this Report
- Biotechnology Innovation Organization (BIO)
- Food and Drug Administration (FDA)
- National Center for Biotechnology Information (NCBI)
- National Science Foundation (NSF)
- Pharmaceutical Research & Manufacturers of America (PhRMA)
- Bio Century
- Thermo Fisher Scientific Inc
- Lonza
- Corning Incorporated
- Kuraray Co Ltd
- Becton, Dickinson and Company
- Merck KGaA
Recent Developments
- January 2021– Corning Incorporated, an American MNC technology company that specializes in ceramics, specialty glass, and related materials and technologies that includes advanced optics, primarily for scientific and industrial applications, introduced latest technologies that would contribute the advancements of 3D cell culture, drug discovery, and automation, at virtual Society for Laboratory Automation and Screening (SLAS) conference.
Report Overview
The report sheds light on 3D cell culture trends to gain insights on the market growth dynamics. The cell culture market forecast comprises market definition and segment overview, along with insights on regional progress of the market. The study of competitive landscape of the 3D cell culture market is also elaborated in the report.
By Technique
Scaffold Based 3D Cell Culture
- Hydrogel-Based Support
- Polymeric Hard Material Based Support
Scaffold Free 3D Cell Culture
- Hanging Drop Microplates
- Spheroid Microplates Containing Ultra-Low Attachment (ULA) Coating
- Microfluidic 3D Cell Culture
By Product
Consumables
- Culture Media
- Reagents
- 3D Multiwell Plates Glassware
Instruments
- Bioreactor
- Flow Cytometer
- Cell Culture Chips
By Application
- Drug Discovery
- Cancer Research
- Stem Cell Research
- Tissue Screening & Engineering
- Regenerative Medicine
By End-Users
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Research & Academic Laboratories
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: USD 3,721 Million |
| CAGR | 16% (2020-2027) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Technique, Product, Application, End User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Biotechnology Innovation Organization (BIO), Food and Drug Administration (FDA), National Center for Biotechnology Information (NCBI), National Science Foundation (NSF), Pharmaceutical Research & Manufacturers of America (PhRMA), Bio Century, Thermo Fisher Scientific Inc, Lonza, Corning Incorporated Kuraray Co Ltd, Becton, Dickinson and Company, Merck KGaA |
| Key Market Opportunities | Entrance of Companies Exploring Untapped Potential of Market |
| Key Market Drivers | Rise in Application of Biotech Applications to Support Market Rise |
Frequently Asked Questions (FAQ) :
The artificially created environment that supports biological cells to grow and interact with their surroundings in all three dimensions is called 3D cell culture.
3D Cell Culture Market is expected to display a CAGR of 16% from 2020 to 2027.
Alarming rate of cancers worldwide and approval of the use of 3D cell culture by government bodies are major factors driving the 3D Cell Culture Market.
The Americas can dominate the 3D cell culture market and accumulate revenues at 27.79% CAGR from 2017 to 2023.
The APAC can display the fastest growth rate of 26.17% from 2017 to 2023.
Kuraray Co Ltd, Lonza, Merck KGaA, Becton, Dickinson and Company, Thermo Fisher Scientific Inc, and Corning Incorporated are the major players in the 3D Cell Culture Market.
